We have described elsewhere (McConkey, Fraser, Bligh, and Whiteley, 1963) an abnormality of the skin which we called transparent skin. In a number of patients, none of whom had rheumatoid disease, we found an association between transparent skin and osteoporosis. We suggested that both the transparency of the skin and the osteoporosis were the consequences of a disorder of connective tissue.
We now report a study of transparent skin and osteoporosis in patients suffering from a known disorder of connective tissue, rheumatoid disease.
Patients and Methods
The patients comprised 102 women aged from 40 to 78 years (mean 58 4); they had had arthritis from 1 to 50 years (mean 11 8).
67 had been treated with corticosteroids, usually prednisone. Where other preparations had been used the dose is expressed as the equivalent amount of prednisone. The total dose varied from 1 * 9 to 28 -8 g.
(mean 12-0); the duration of treatment from 10 to 84 months (mean 42), and the daily dose varied from 5 to 15 7 mg. (mean 9 5).
The skin on the dorsum of the hand in each patient was classified as transparent, opaque, or doubtful. In 57 patients we also measured the thickness of a fold of skin on the dorsum of the hand over the 4th metacarpal using a Harpenden caliper and measuring the skin fold three times in each patient. We also noted any purpura * Based on a paper read to the Heberden Society on February 26, 1965. of the "senile" or "steroid" type (Scarborough and Shuster, 1960; Shuster and Scarborough, 1961) .
In the 74 patients who were x-rayed osteoporosis was diagnosed by the same criteria as before (McConkey, Fraser, and Bligh, 1962) .
Results
Transparent Skin and Rheumatoid Disease.- Table I shows the prevalence of transparent skin in the 102 women with rheumatoid disease and in 200 women with other diseases. In each decade from 40 to 80 years, transparent skin was more common in the patients with rheumatoid disease.
Of the women with rheumatoid disease, 35 (mean age 58 5 years) had not received corticosteroids; in them the prevalence of transparent skin was 34 per cent. Table I shows that the highest incidence of transparent skin in the controls (in the eighth decade) was only 12 per cent. Thus the incidence of transparent skin is high in patients with rheumatoid disease, irrespective of treatment with corticosteroids.
Patients with transparent skin had usually had rheumatoid disease longer than those with opaque skin (mean duration 16' 2 and 10 3 years respectively). Transparent Skin and Corticosteroid Therapy.-To investigate whether corticosteroids contributed to the development of transparent skin, we compared the 67 women who had had corticosteroids with the 35 who had not had this treatment. The groups were well matched in age (mean 58 * 4 and 58 * 6 years) and in the duration of arthritis (mean 11 7 and 12 3 years). Table II shows how the patients were classified; there were more "doubtful" patients in the treated group than in the untreated group. The patients with transparent skin were older than the rest, but the difference in age does not account for the difference in the incidence of osteoporosis. Thus Table V shows the findings in patients who had had corticosteroids, and the 22 with transparent skin are compared with eighteen patients with opaque skin aged more than 55 years. Although the mean ages were similar, osteoporosis was much more common (0-01> P >0-001) in the patients with transparent skin. It is unlikely that the small differences in duration of rheumatoid disease and amount of treatment with corticosteroids could account for the large difference in the incidence of osteoporosis. (McConkey and others, 1963) . Thus transparent skin is usually thin skin, but the measurements in patients with opaque and transparent skin overlap.
We have considered further the patients in the range of overlap. There were 25 patients whose skin-fold measurements were between 1 3 and 1-7 mm.; eleven had transparent skin and fourteen had opaque or doubtful skin. Of the eleven with transparent skin, nine had osteoporosis, three of them with vertebral fractures. Of the fourteen with opaque skin, three had osteoporosis but none had vertebral fractures. These figures suggest that it is transparency, rather than thinness, of the skin which is associated with osteoporosis.
However, as transparent skin is usually thin skin, osteoporosis could have been predicted in these patients nearly as well from the skin-fold thickness as from the transparency. Of the 51 patients whose skin-fold thickness was known and who had been x-rayed, 21 had transparent skin; of these sixteen (76 per cent.) had osteoporosis. 26 had skin-fold measurements less than 1 -6 mm.; of these sixteen (62 per cent.) had osteoporosis (Table VI) .
Discussion
The prevalence of transparent skin and its relation to osteoporosis has been described before in patients suffering from diseases other than rheumatoid arthritis (McConkey and others, 1963) . We now show that transparent skin is commoner in women with rheumatoid disease, and usually affects patients who have had arthritis for many years. The finding supports the view that transparent skin is the consequence of a disorder of connective tissue.
Treatment with adrenal corticosteroids influences the connective tissue of the skin; the effects have been investigated in animals (Layton, 1951; Smith, 1962) and no doubt account for corticosteroid purpura in man. In our patients corticosteroids had certainly had an effect on the skin, for purpura was found more often in those who had had such treatment. There was no evidence that the corticosteroids had contributed to the development of transparent skin, though the effects of age and of the rheumatoid disease could have masked such an effect. Younger patients, receiving corticosteroids for a disease not associated with transparent skin, might provide an answer to this question.
There are also difficulties in assessing the contribution of corticosteroids to the development of osteoporosis in rheumatoid disease. Age and the rheumatoid disease itself are contributory factors which may be at least as important (McConkey and others, 1962) . In the present study, the prevalence of osteoporosis in treated and untreated patients did not differ significantly, irrespective of whether the patients about whom the radiologists disagreed were regarded as normal or abnormal (P 0 and P 0-20 respectively). Yet all the patients with fractures were in the treated group and the data in Table IV also suggest that corticosteroids contributed to the osteoporosis. (McConkey and others, 1962) . In the present study the findings were similar; osteoporosis was commoner in patients with purpura (52 per cent.) than in patients without purpura (29 per cent.). However, there is also an association between purpura and transparent skin (McConkey and others, 1963) . Table VII shows the results when the three variables are taken into account; patients with transparent skin are likely to have osteoporosis whether they have purpura or not.
The data on transparent skin and osteoporosis shown in Tables IV and V suggest a direct relationship. Transparent skin is usually thin skin. Osteoporosis was, in fact, found almost as often in patients with thin skin (skin-fold measurement less than 1 6 mm.) as in patients whose skin looked transparent. But when we compared groups ofpatients with opaque and transparent skin whose skin-fold thicknesses were similar, we found that osteoporosis was commoner in those with transparent skin. There must, therefore, have been some change in the skin, in addition to loss of substance, which made it look transparent and which was closely associated with osteoporosis.
This change in the skin can be recognized histologically. Dr. K. W. Walton has recently examined biopsy specimens of opaque and transparent skin of the same thickness, taken from pairs of patients matched for sex and age. The difference between opaque and transparent skin, which we shall describe fully when the work is complete, is most obvious in the collagen of the dernis.
This study of transparent skin in patients with rheumatoid disease supports the findings of our previous study of patients with other diseases. In both studies we found that transparent skin and osteoporosis were associated, that transparent skin is usually thin skin, and that it is its transparency, rather than its thinness, which is associated with osteoporosis. Transparent skin and osteoporosis are found together more often in patients with rheumatoid disease, a known disorder of connective tissue, than in patients with other diseases. Indeed transparent skin was found in about 35 per cent. of patients with osteoporosis from any cause (unpublished observations), but in 22 of 28 (78 5 per cent.) of patients with osteoporosis and rheumatoid disease. Osteoporosis is probably not one disease but an accompaniment of a number of disorders with different causes; one type is associated with transparent skin. We suggest that when osteoporosis is accompanied by transparent skin a disorder of connective tissue underlies both phenomena. Summary The prevalence of transparent skin and its relationship to osteoporosis has been studied in 102 women, all over the age of 40, with rheumatoid disease.
Transparent skin was found more often in the 102 women with rheumatoid disease, whether they had had corticosteroids or not, than in 200 women with other diseases. The finding supports the view that transparent skin is the consequence of a disorder of connective tissue.
Women who had transparent skin had usually had arthritis for many years.
The prevalence of transparent skin in women who had and who had not had corticosteroids did not differ significantly; purpura, a known complication of corticosteroid therapy, was more common in the treated group. Thus corticosteroids had apparently not helped the development of transparent skin.
There was a close association between transparent skin and osteoporosis. Transparent skin is usually thin skin; osteoporosis was therefore nearly as common in women with thin skin (skin-fold < I 6 mm.) as in those whose skin looked transparent. However, when we compared patients who matched in respect of skin-fold thickness, we found that osteoporosis was more closely associated with transparency than with thinness of the skin.
We wish to thank Dr. DR. V. WRIGHT (Leeds): This is tremendously important because it provides strong circumstantial evidence which may resolve the conflict between those who think osteoporosis is due to a calcium drain and those who think it has primarily to do with collagen. I should like to ask if you grade the transparency of the skin? What is your observer error in assessing the transparency? Have you looked for it elsewhere and have you done skin fold measurements? I should also be interested to know if you have any data on post-pregnancy osteoporosis. We have done stress-strain analyses on the skin of some of these patients, and these differ from those of rheumatoid arthritis.
DR. MCCONKEY: Osteoporosis is not a single disease but a number of conditions-one type is associated with transparent skin. In patients with osteoporosis, about 35 per cent. have transparent skin, but in those with rheumatoid arthritis and osteoporosis the figure is 80 per cent. We did not attempt clinical grading, but divided skins into either definitely "opaque" or "transparent", or "do not know". I do not know the observer error. Thin skin can be seen elsewhere, but more work on the histology is necessary. We have measured skin-fold thickness, but there are not many parts of the body where one can do this without including fat. I have no comment on postpregnancy osteoporosis.
La peau transparente et l'osteoporose. Une etude des malades atteintes de maladie rhumatoide RESUME On etudia la frequence de la peau transparente et son rapport a l'osteoporose chez 102 femmes, toutes agees de plus de 40 ans et atteintes de maladie rhumatoide.
La peau transparente fut trouvee plus souvent chez les 102 femmes atteintes de maladie rhumatoide, avec ou sans traitement corticosteroide, que chez 200 femmes atteintes d'autres maladies. Ce resultat vient a l'appui de l'hypothese que la peau transparente est une consequence d'un desordre du tissu conjonctif.
Les femmes a la peau transparente souffraient generalement de leur arthrite depuis plusieurs annees.
La frequence de la peau transparente chez des femmes traitees et non-traitees par des corticosteroides n'accusa pas de difference significative; le purpura, complication bien connue de la therapie corticosteroide, fut plus commun dans le groupe traite. Apparemment, les corticosteroides n'avaient pas contribue au developpement de la peau transparente.
I1 y eut une association etroite entre la peau transparente et l'osteoporose. Une peau transparente est generalement une peau mince; l'osteoporose fut donc presque aussi frequente chez des femmes avec une peau mince (pli cutane <1,6 mm.) que chez celles dont la peau parut transparente. Toutefois, lorsqu'on compara les malades assortis selon l'epaisseur de leur peau, on trouva que l'osteoporose fut plus associee a la transparence de la peau qu'a son epaisseur.
La piel transparente y la osteoporosis. Un estudio de enfermas reumatoides SUMARIO Se estudi6 la frecuencia de la piel transparente y su relaci6n con la osteoporosis en 102 mujeres, de mAs de 40 afios, sufriendo de enfermedad reumatoide.
La piel transparente fue encontrada mas a menudo en las 102 mujeres con enfermedad reumatoide, tratadas o no con corticosteroides, que en 200 mujeres con otras enfermedades. Este resultado sostiene la hipotesis de que la piel transparente es una consecuencia de un disturbio del tejido conectivo.
Las mujeres con piel transparente sufrian generalmente de su artritis desde muchos afnos.
La frecuencia de la piel transparente en muj,res tratadas o no con corticosteroides no acus6 diferencia significativa; el puirpura, complicacion bien conocida de la terapia corticosteroide, fue mas comun en el grupo tratado. Aparentemente, los corticosteroides no habian contribuido al desarrollo de la piel transparente.
Hubo asociaci6n estrecha entre la piel transparente y la osteoporosis. Una piel transparente es generalemente una piel delgada; la osteoporosis fue pues casi tan frecuente en las mujeres con piel delgada (pliegue cutAneo < 1,6 mm.) que en las cuya piel pareci6 transparente. Sin embargo, al comparar las enfermas apareadas segun la espesura del pliegue cutaneo, se vi6 que la osteoporosis fue mas asociada a la transparencia de la piel que a su espesor.
